Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies

Journal Article

2014

Permanent link to this Item
http://hdl.handle.net/11427/34710
Files
BoulleAndrew_Mortality_in_Pa_2014.pdf (779.12 KB)
Authors
Boulle, Andrew
Schomaker, Michael
Garone, Daniela
Fox, Matthew
Ingle, Suzanne M
Reiss, Peter
Dabis, François
Costagliola, Dominique
Castagna, Antonella
Ehren, Kathrin
Campbell, Colin
Gill, M John
May, Margaret T
Saag, Michael
Justice, Amy C
Guest, Jodie
Crane, Heidi M
Egger, Matthias
Sterne, Jonathan A C
Hogg, Robert S
Shepherd, Bryan E
Monge, Susana
Keiser, Olivia
Lampe, Fiona C
Giddy, Janet
Ndirangu, James
Journal Title

PLoS Medicine

Link to Journal
https://dx.doi.org/10.1371/journal.pmed.1001718
Journal ISSN
Volume Title
Publisher
Publisher
Department
Department of Public Health and Family Medicine
Faculty
Faculty of Health Sciences
License
Series
Abstract
High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Africa, compared to Europe and North America, is well documented. Longer-term comparisons between settings have been limited by poor ascertainment of mortality in high burden African settings. This study aimed to compare mortality up to four years on ART between South Africa, Europe, and North America.
Description
Keywords
Adult
Anti-HIV Agents
Humans
Male
Middle Aged
Mortality
North America
Prospective Studies
South Africa
Antiretroviral Therapy, Highly Active
Cohort Studies
Cooperative Behavior
Europe
Female
Follow-Up Studies
HIV Infections
HIV-1

Reference:

Boulle, A., Schomaker, M., May, M.T., Hogg, R.S., Shepherd, B.E., Monge, S., Keiser, O. & Lampe, F.C. et al. 2014. Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies. PLoS Medicine. 11(9):e1001718 - 177. http://hdl.handle.net/11427/34710

Collections
Journal Articles